NCT01747928View on ClinicalTrials.gov

Users Study Of The Caverject Delivery System

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
OTHER

dual-chamber syringe

dual-chamber syringe for mock injection

Trial Locations (1)

66212

Vince and Associates Clinical Research, Overland Park

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01747928 - Users Study Of The Caverject Delivery System | Biotech Hunter | Biotech Hunter